News Summary

• Johnson & Johnson (NYSE:JNJ) was among Jim Cramer’s stock calls on Mad Money recently.
• Cramer highlighted buying the stock for the Charitable Trust, as he stated: We’re buying what may be the best drug stock, or at least the second-best if you're Eli Lilly.
• The company decided to spin off its orthopedics business as a standalone company.
• This is a slower-growing piece of the pie, so the breakup will help unlock value.